These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 9029093

  • 1. A major role for matrix metalloproteinases in T cell injury in the gut.
    Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT.
    J Immunol; 1997 Feb 15; 158(4):1582-90. PubMed ID: 9029093
    [Abstract] [Full Text] [Related]

  • 2. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production.
    Pender SL, Fell JM, Chamow SM, Ashkenazi A, MacDonald TT.
    J Immunol; 1998 Apr 15; 160(8):4098-103. PubMed ID: 9558121
    [Abstract] [Full Text] [Related]

  • 3. Suppression of T cell-mediated injury in human gut by interleukin 10: role of matrix metalloproteinases.
    Pender SL, Breese EJ, Günther U, Howie D, Wathen NC, Schuppan D, MacDonald TT.
    Gastroenterology; 1998 Sep 15; 115(3):573-83. PubMed ID: 9721154
    [Abstract] [Full Text] [Related]

  • 4. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone.
    Samples JR, Alexander JP, Acott TS.
    Invest Ophthalmol Vis Sci; 1993 Nov 15; 34(12):3386-95. PubMed ID: 8225873
    [Abstract] [Full Text] [Related]

  • 5. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR, Gomez DE, Nason AM, Thorgeirsson UP.
    Lab Invest; 1994 Jun 15; 70(6):800-6. PubMed ID: 8015284
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
    Burger D, Rezzonico R, Li JM, Modoux C, Pierce RA, Welgus HG, Dayer JM.
    Arthritis Rheum; 1998 Oct 15; 41(10):1748-59. PubMed ID: 9778216
    [Abstract] [Full Text] [Related]

  • 8. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP.
    Invasion Metastasis; 1992 Oct 15; 12(3-4):168-84. PubMed ID: 1284126
    [Abstract] [Full Text] [Related]

  • 9. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
    Saarialho-Kere UK, Vaalamo M, Puolakkainen P, Airola K, Parks WC, Karjalainen-Lindsberg ML.
    Am J Pathol; 1996 Feb 15; 148(2):519-26. PubMed ID: 8579114
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinases in periodontal tissue remodelling.
    Sodek J, Overall CM.
    Matrix Suppl; 1992 Feb 15; 1():352-62. PubMed ID: 1480060
    [Abstract] [Full Text] [Related]

  • 12. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
    Schönbeck U, Mach F, Libby P.
    J Immunol; 1998 Oct 01; 161(7):3340-6. PubMed ID: 9759850
    [Abstract] [Full Text] [Related]

  • 13. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations.
    Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U.
    Am J Pathol; 1998 Apr 01; 152(4):1005-14. PubMed ID: 9546361
    [Abstract] [Full Text] [Related]

  • 14. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR.
    Oncol Res; 1993 Apr 01; 5(1):19-28. PubMed ID: 8369572
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP.
    Lab Invest; 1994 Jun 01; 70(6):807-15. PubMed ID: 8015285
    [Abstract] [Full Text] [Related]

  • 17. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B).
    Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK.
    J Cell Physiol; 1993 Dec 01; 157(3):644-9. PubMed ID: 8253876
    [Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.
    Tao Y, Bazan HE, Bazan NG.
    Invest Ophthalmol Vis Sci; 1995 Feb 01; 36(2):345-54. PubMed ID: 7843905
    [Abstract] [Full Text] [Related]

  • 19. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH, Lottspeich F, Ries C, Petrides PE.
    Exp Hematol; 1995 Feb 01; 23(2):155-60. PubMed ID: 7828672
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.
    Salmela MT, MacDonald TT, Black D, Irvine B, Zhuma T, Saarialho-Kere U, Pender SL.
    Gut; 2002 Oct 01; 51(4):540-7. PubMed ID: 12235077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.